Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein | 0.0263 | 0.8315 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0181 | 1 |
Schistosoma mansoni | ubiquitin-activating enzyme E1C | 0.0067 | 0.1593 | 0.0751 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.0998 | 0.0097 |
Trypanosoma cruzi | hypothetical protein | 0.0263 | 0.8315 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.091 | 0.0743 |
Echinococcus multilocularis | NEDD8 activating enzyme E1 catalytic subunit | 0.0067 | 0.1593 | 0.1009 |
Trypanosoma brucei | nucleoside 2-deoxyribosyltransferase | 0.0263 | 0.8315 | 1 |
Toxoplasma gondii | NEDD8-activating enzyme E1 catalytic subunit | 0.0067 | 0.1593 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0244 | 0.7681 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0312 | 1 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0244 | 0.7681 | 1 |
Loa Loa (eye worm) | ectopic membrane ruffles in embryo protein 1 | 0.0067 | 0.1593 | 0.1438 |
Echinococcus granulosus | NEDD8 activating enzyme E1 catalytic subunit | 0.0067 | 0.1593 | 0.1009 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0263 | 0.8315 | 1 |
Trichomonas vaginalis | ubiquitin-activating enzyme E1, putative | 0.0048 | 0.095 | 0.095 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0181 | 1 |
Onchocerca volvulus | 0.005 | 0.0998 | 0.5 | |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.005 | 0.0998 | 0.0833 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.5238 | 0.4762 |
Entamoeba histolytica | ubiquitin-activating enzyme, putative | 0.0067 | 0.1593 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.091 | 0.0743 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0241 | 0.7557 | 0.7512 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0181 | 0.0218 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0181 | 0.0218 |
Brugia malayi | Ectopic membrane ruffles in embryo protein 1 | 0.0067 | 0.1593 | 0.1438 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0263 | 0.8315 | 1 |
Echinococcus granulosus | geminin | 0.0173 | 0.5238 | 0.6392 |
Leishmania major | hypothetical protein, conserved | 0.0263 | 0.8315 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0181 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0181 | 0.0218 |
Brugia malayi | hypothetical protein | 0.0244 | 0.7681 | 0.7639 |
Trichomonas vaginalis | glutaminase, putative | 0.0312 | 1 | 1 |
Schistosoma mansoni | glutaminase | 0.0312 | 1 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.005 | 0.0998 | 0.0097 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0263 | 0.8315 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0312 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0173 | 0.5238 | 0.4762 |
Echinococcus multilocularis | geminin | 0.0173 | 0.5238 | 0.6392 |
Brugia malayi | MH2 domain containing protein | 0.0241 | 0.7557 | 0.7512 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0181 | 0.0218 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0263 | 0.8315 | 0.8315 |
Loa Loa (eye worm) | glutaminase | 0.0312 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0244 | 0.7681 | 0.7639 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0241 | 0.7557 | 0.7512 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | NA 0 % | Percent inhibition of caster oil induced diarrhea in rats at a dose of 30 mg/kg peroral administration after 2 hours; NS=Not siginificant | ChEMBL. | 3906127 |
Inhibition (functional) | NA 0 % | Percent inhibition of caster oil induced diarrhea in rats at a dose of 30 mg/kg peroral administration after 6 hours; NS=Not siginificant | ChEMBL. | 3906127 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.